QY Research > レポート一覧 > 薬品及びサプリメント > スウェーデンのポルフィリン世界市場の発展状況と動向 2024-2030

スウェーデンのポルフィリン世界市場の発展状況と動向 2024-2030

英文タイトル: Global Swedish Porphyria Market Insights, Forecast to 2030

スウェーデンのポルフィリン世界市場の発展状況と動向 2024-2030
  • レポートID:269654
  • 発表時期:2024-04-25
  • 訪問回数:1021
  • ページ数:76
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:104
  • レポートカテゴリ: 薬品及びサプリメント

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

shenQingYangBen

お見積

shenQingYangBen

サンプルお申込み

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書は、スウェーデンのポルフィリンの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にスウェーデンのポルフィリン市場を分類しています。

本レポートでは世界のスウェーデンのポルフィリン市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は:Recordati Rare Diseases

レポートはスウェーデンのポルフィリンの主要生産者を調査し、主要地域や国の消費状況も提供します。スウェーデンのポルフィリンの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。

タイプ別市場セグメント:
350mg
313mg

用途別の市場セグメント:
Hospital
Pharmacy

レポートの詳細内容
本レポートは、世界のスウェーデンのポルフィリン市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてスウェーデンのポルフィリン市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。

一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別(地域レベル、国レベル)のスウェーデンのポルフィリン生産量、成長率、市場シェアを調査している。

二. 消費面では、スウェーデンのポルフィリンの売上高を地域別(地域レベル・国レベル)、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのスウェーデンのポルフィリン売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のスウェーデンのポルフィリン市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本スウェーデンのポルフィリンのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要

1章:スウェーデンのポルフィリンのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー(タイプ別およびアプリケーション別など)を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。(20192030
2章: スウェーデンのポルフィリンの世界と主要生産者(地域/国)の生産/アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。(20192030
3章:世界、地域、国レベルにおけるスウェーデンのポルフィリンの売上(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。(20192030
4スウェーデンのポルフィリンメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。(20192024
5章:スウェーデンのポルフィリンの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20192030
6章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。(20192030
7章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。(20192030
8章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。(20192030
9章:中国:タイプ別、アプリケーション別、セグメント別の売上高、収益。(20192030
10章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。(20192030
11章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。(20192030
12章:スウェーデンのポルフィリンの主要メーカーの概要を提供し、製品の説明と仕様、スウェーデンのポルフィリンの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。(20192024
13章:産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
14章:スウェーデンのポルフィリンの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
15章:レポートの要点と結論。

biaoTi

概要

Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias.
The global Swedish Porphyria market is projected to grow from US$ 50 million in 2024 to US$ 56 million by 2030, at a Compound Annual Growth Rate (CAGR) of 1.8% during the forecast period.
Panhematin (hemin) is a medication used to treat acute porphyria, a rare genetic disorder that affects heme production. Its effectiveness in managing acute porphyria attacks and reducing symptoms has driven market growth. The rarity of the condition and limited treatment options contribute to its niche status. However, challenges include the need for careful monitoring and potential side effects. The market competition is relatively small, as Panhematin remains a specialized therapy. 
Report Covers:
This report presents an overview of global market for Swedish Porphyria, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Swedish Porphyria, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Swedish Porphyria, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Swedish Porphyria sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Swedish Porphyria market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Swedish Porphyria sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Recordati Rare Diseases. etc.
Market Segmentation
By Company
    Recordati Rare Diseases

Segment by Type
    350mg
    313mg

Segment by Application
    Hospital
    Pharmacy

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Swedish Porphyria in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Swedish Porphyria manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swedish Porphyria sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
biaoTi

総目録

1 Study Coverage
1.1 Swedish Porphyria Product Introduction
1.2 Market by Type
1.2.1 Global Swedish Porphyria Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 350mg
1.2.3 313mg
1.3 Market by Application
1.3.1 Global Swedish Porphyria Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Swedish Porphyria Sales Estimates and Forecasts 2019-2030
2.2 Global Swedish Porphyria Revenue by Region
2.2.1 Global Swedish Porphyria Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Swedish Porphyria Revenue by Region (2019-2024)
2.2.3 Global Swedish Porphyria Revenue by Region (2025-2030)
2.2.4 Global Swedish Porphyria Revenue Market Share by Region (2019-2030)
2.3 Global Swedish Porphyria Sales Estimates and Forecasts 2019-2030
2.4 Global Swedish Porphyria Sales by Region
2.4.1 Global Swedish Porphyria Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Swedish Porphyria Sales by Region (2019-2024)
2.4.3 Global Swedish Porphyria Sales by Region (2025-2030)
2.4.4 Global Swedish Porphyria Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 Competition by Manufactures
3.1 Global Swedish Porphyria Sales by Manufacturers
3.1.1 Global Swedish Porphyria Sales by Manufacturers (2019-2024)
3.1.2 Global Swedish Porphyria Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Swedish Porphyria in 2023
3.2 Global Swedish Porphyria Revenue by Manufacturers
3.2.1 Global Swedish Porphyria Revenue by Manufacturers (2019-2024)
3.2.2 Global Swedish Porphyria Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Swedish Porphyria Revenue in 2023
3.3 Global Key Players of Swedish Porphyria, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Swedish Porphyria Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Swedish Porphyria Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Swedish Porphyria, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Swedish Porphyria, Product Offered and Application
3.8 Global Key Manufacturers of Swedish Porphyria, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Swedish Porphyria Sales by Type
4.1.1 Global Swedish Porphyria Historical Sales by Type (2019-2024)
4.1.2 Global Swedish Porphyria Forecasted Sales by Type (2025-2030)
4.1.3 Global Swedish Porphyria Sales Market Share by Type (2019-2030)
4.2 Global Swedish Porphyria Revenue by Type
4.2.1 Global Swedish Porphyria Historical Revenue by Type (2019-2024)
4.2.2 Global Swedish Porphyria Forecasted Revenue by Type (2025-2030)
4.2.3 Global Swedish Porphyria Revenue Market Share by Type (2019-2030)
4.3 Global Swedish Porphyria Price by Type
4.3.1 Global Swedish Porphyria Price by Type (2019-2024)
4.3.2 Global Swedish Porphyria Price Forecast by Type (2025-2030)

5 Market Size by Application
5.1 Global Swedish Porphyria Sales by Application
5.1.1 Global Swedish Porphyria Historical Sales by Application (2019-2024)
5.1.2 Global Swedish Porphyria Forecasted Sales by Application (2025-2030)
5.1.3 Global Swedish Porphyria Sales Market Share by Application (2019-2030)
5.2 Global Swedish Porphyria Revenue by Application
5.2.1 Global Swedish Porphyria Historical Revenue by Application (2019-2024)
5.2.2 Global Swedish Porphyria Forecasted Revenue by Application (2025-2030)
5.2.3 Global Swedish Porphyria Revenue Market Share by Application (2019-2030)
5.3 Global Swedish Porphyria Price by Application
5.3.1 Global Swedish Porphyria Price by Application (2019-2024)
5.3.2 Global Swedish Porphyria Price Forecast by Application (2025-2030)

6 US & Canada
6.1 US & Canada Swedish Porphyria Market Size by Type
6.1.1 US & Canada Swedish Porphyria Sales by Type (2019-2030)
6.1.2 US & Canada Swedish Porphyria Revenue by Type (2019-2030)
6.2 US & Canada Swedish Porphyria Market Size by Application
6.2.1 US & Canada Swedish Porphyria Sales by Application (2019-2030)
6.2.2 US & Canada Swedish Porphyria Revenue by Application (2019-2030)
6.3 US & Canada Swedish Porphyria Market Size by Country
6.3.1 US & Canada Swedish Porphyria Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Swedish Porphyria Sales by Country (2019-2030)
6.3.3 US & Canada Swedish Porphyria Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada

7 Europe
7.1 Europe Swedish Porphyria Market Size by Type
7.1.1 Europe Swedish Porphyria Sales by Type (2019-2030)
7.1.2 Europe Swedish Porphyria Revenue by Type (2019-2030)
7.2 Europe Swedish Porphyria Market Size by Application
7.2.1 Europe Swedish Porphyria Sales by Application (2019-2030)
7.2.2 Europe Swedish Porphyria Revenue by Application (2019-2030)
7.3 Europe Swedish Porphyria Market Size by Country
7.3.1 Europe Swedish Porphyria Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Swedish Porphyria Sales by Country (2019-2030)
7.3.3 Europe Swedish Porphyria Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia

8 China
8.1 China Swedish Porphyria Market Size
8.1.1 China Swedish Porphyria Sales (2019-2030)
8.1.2 China Swedish Porphyria Revenue (2019-2030)
8.2 China Swedish Porphyria Market Size by Application
8.2.1 China Swedish Porphyria Sales by Application (2019-2030)
8.2.2 China Swedish Porphyria Revenue by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Swedish Porphyria Market Size by Type
9.1.1 Asia Swedish Porphyria Sales by Type (2019-2030)
9.1.2 Asia Swedish Porphyria Revenue by Type (2019-2030)
9.2 Asia Swedish Porphyria Market Size by Application
9.2.1 Asia Swedish Porphyria Sales by Application (2019-2030)
9.2.2 Asia Swedish Porphyria Revenue by Application (2019-2030)
9.3 Asia Swedish Porphyria Sales by Region
9.3.1 Asia Swedish Porphyria Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Swedish Porphyria Revenue by Region (2019-2030)
9.3.3 Asia Swedish Porphyria Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India

10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Swedish Porphyria Market Size by Type
10.1.1 Middle East, Africa and Latin America Swedish Porphyria Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Swedish Porphyria Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Swedish Porphyria Market Size by Application
10.2.1 Middle East, Africa and Latin America Swedish Porphyria Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Swedish Porphyria Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Swedish Porphyria Sales by Country
10.3.1 Middle East, Africa and Latin America Swedish Porphyria Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Swedish Porphyria Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Swedish Porphyria Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries

11 Company Profiles
11.1 Recordati Rare Diseases
11.1.1 Recordati Rare Diseases Company Information
11.1.2 Recordati Rare Diseases Overview
11.1.3 Recordati Rare Diseases Swedish Porphyria Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Recordati Rare Diseases Swedish Porphyria Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Recordati Rare Diseases Recent Developments

12 Industry Chain and Sales Channels Analysis
12.1 Swedish Porphyria Industry Chain Analysis
12.2 Swedish Porphyria Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Swedish Porphyria Production Mode & Process
12.4 Swedish Porphyria Sales and Marketing
12.4.1 Swedish Porphyria Sales Channels
12.4.2 Swedish Porphyria Distributors
12.5 Swedish Porphyria Customers

13 Market Dynamics
13.1 Swedish Porphyria Industry Trends
13.2 Swedish Porphyria Market Drivers
13.3 Swedish Porphyria Market Challenges
13.4 Swedish Porphyria Market Restraints

14 Key Findings in The Global Swedish Porphyria Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

biaoTi

表と図のリスト

List of Tables
    Table 1. Global Swedish Porphyria Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of 350mg
    Table 3. Major Manufacturers of 313mg
    Table 4. Global Swedish Porphyria Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Swedish Porphyria Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Swedish Porphyria Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Swedish Porphyria Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Swedish Porphyria Revenue Market Share by Region (2019-2024)
    Table 9. Global Swedish Porphyria Revenue Market Share by Region (2025-2030)
    Table 10. Global Swedish Porphyria Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Swedish Porphyria Sales by Region (2019-2024) & (Units)
    Table 12. Global Swedish Porphyria Sales by Region (2025-2030) & (Units)
    Table 13. Global Swedish Porphyria Sales Market Share by Region (2019-2024)
    Table 14. Global Swedish Porphyria Sales Market Share by Region (2025-2030)
    Table 15. Global Swedish Porphyria Sales by Manufacturers (2019-2024) & (Units)
    Table 16. Global Swedish Porphyria Sales Share by Manufacturers (2019-2024)
    Table 17. Global Swedish Porphyria Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Swedish Porphyria Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Swedish Porphyria, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Swedish Porphyria Price by Manufacturers 2019-2024 (USD/Unit)
    Table 21. Global Swedish Porphyria Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Swedish Porphyria by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swedish Porphyria as of 2023)
    Table 23. Global Key Manufacturers of Swedish Porphyria, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Swedish Porphyria, Product Offered and Application
    Table 25. Global Key Manufacturers of Swedish Porphyria, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Swedish Porphyria Sales by Type (2019-2024) & (Units)
    Table 28. Global Swedish Porphyria Sales by Type (2025-2030) & (Units)
    Table 29. Global Swedish Porphyria Sales Share by Type (2019-2024)
    Table 30. Global Swedish Porphyria Sales Share by Type (2025-2030)
    Table 31. Global Swedish Porphyria Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Swedish Porphyria Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Swedish Porphyria Revenue Share by Type (2019-2024)
    Table 34. Global Swedish Porphyria Revenue Share by Type (2025-2030)
    Table 35. Swedish Porphyria Price by Type (2019-2024) & (USD/Unit)
    Table 36. Global Swedish Porphyria Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 37. Global Swedish Porphyria Sales by Application (2019-2024) & (Units)
    Table 38. Global Swedish Porphyria Sales by Application (2025-2030) & (Units)
    Table 39. Global Swedish Porphyria Sales Share by Application (2019-2024)
    Table 40. Global Swedish Porphyria Sales Share by Application (2025-2030)
    Table 41. Global Swedish Porphyria Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Swedish Porphyria Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Swedish Porphyria Revenue Share by Application (2019-2024)
    Table 44. Global Swedish Porphyria Revenue Share by Application (2025-2030)
    Table 45. Swedish Porphyria Price by Application (2019-2024) & (USD/Unit)
    Table 46. Global Swedish Porphyria Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 47. US & Canada Swedish Porphyria Sales by Type (2019-2024) & (Units)
    Table 48. US & Canada Swedish Porphyria Sales by Type (2025-2030) & (Units)
    Table 49. US & Canada Swedish Porphyria Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Swedish Porphyria Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Swedish Porphyria Sales by Application (2019-2024) & (Units)
    Table 52. US & Canada Swedish Porphyria Sales by Application (2025-2030) & (Units)
    Table 53. US & Canada Swedish Porphyria Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Swedish Porphyria Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Swedish Porphyria Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Swedish Porphyria Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Swedish Porphyria Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Swedish Porphyria Sales by Country (2019-2024) & (Units)
    Table 59. US & Canada Swedish Porphyria Sales by Country (2025-2030) & (Units)
    Table 60. Europe Swedish Porphyria Sales by Type (2019-2024) & (Units)
    Table 61. Europe Swedish Porphyria Sales by Type (2025-2030) & (Units)
    Table 62. Europe Swedish Porphyria Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Swedish Porphyria Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Swedish Porphyria Sales by Application (2019-2024) & (Units)
    Table 65. Europe Swedish Porphyria Sales by Application (2025-2030) & (Units)
    Table 66. Europe Swedish Porphyria Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Swedish Porphyria Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Swedish Porphyria Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Swedish Porphyria Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Swedish Porphyria Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Swedish Porphyria Sales by Country (2019-2024) & (Units)
    Table 72. Europe Swedish Porphyria Sales by Country (2025-2030) & (Units)
    Table 73. China Swedish Porphyria Sales by Type (2019-2024) & (Units)
    Table 74. China Swedish Porphyria Sales by Type (2025-2030) & (Units)
    Table 75. China Swedish Porphyria Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Swedish Porphyria Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Swedish Porphyria Sales by Application (2019-2024) & (Units)
    Table 78. China Swedish Porphyria Sales by Application (2025-2030) & (Units)
    Table 79. China Swedish Porphyria Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Swedish Porphyria Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Swedish Porphyria Sales by Type (2019-2024) & (Units)
    Table 82. Asia Swedish Porphyria Sales by Type (2025-2030) & (Units)
    Table 83. Asia Swedish Porphyria Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Swedish Porphyria Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Swedish Porphyria Sales by Application (2019-2024) & (Units)
    Table 86. Asia Swedish Porphyria Sales by Application (2025-2030) & (Units)
    Table 87. Asia Swedish Porphyria Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Swedish Porphyria Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Swedish Porphyria Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Swedish Porphyria Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Swedish Porphyria Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Swedish Porphyria Sales by Region (2019-2024) & (Units)
    Table 93. Asia Swedish Porphyria Sales by Region (2025-2030) & (Units)
    Table 94. Middle East, Africa and Latin America Swedish Porphyria Sales by Type (2019-2024) & (Units)
    Table 95. Middle East, Africa and Latin America Swedish Porphyria Sales by Type (2025-2030) & (Units)
    Table 96. Middle East, Africa and Latin America Swedish Porphyria Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Swedish Porphyria Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Swedish Porphyria Sales by Application (2019-2024) & (Units)
    Table 99. Middle East, Africa and Latin America Swedish Porphyria Sales by Application (2025-2030) & (Units)
    Table 100. Middle East, Africa and Latin America Swedish Porphyria Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Swedish Porphyria Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Swedish Porphyria Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Swedish Porphyria Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Swedish Porphyria Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Swedish Porphyria Sales by Country (2019-2024) & (Units)
    Table 106. Middle East, Africa and Latin America Swedish Porphyria Sales by Country (2025-2030) & (Units)
    Table 107. Recordati Rare Diseases Company Information
    Table 108. Recordati Rare Diseases Description and Major Businesses
    Table 109. Recordati Rare Diseases Swedish Porphyria Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Recordati Rare Diseases Swedish Porphyria Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Recordati Rare Diseases Recent Developments
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Swedish Porphyria Distributors List
    Table 115. Swedish Porphyria Customers List
    Table 116. Swedish Porphyria Market Trends
    Table 117. Swedish Porphyria Market Drivers
    Table 118. Swedish Porphyria Market Challenges
    Table 119. Swedish Porphyria Market Restraints
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Swedish Porphyria Product Picture
    Figure 2. Global Swedish Porphyria Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Swedish Porphyria Market Share by Type in 2023 & 2030
    Figure 4. 350mg Product Picture
    Figure 5. 313mg Product Picture
    Figure 6. Global Swedish Porphyria Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Swedish Porphyria Market Share by Application in 2023 & 2030
    Figure 8. Hospital
    Figure 9. Pharmacy
    Figure 10. Swedish Porphyria Report Years Considered
    Figure 11. Global Swedish Porphyria Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Swedish Porphyria Revenue 2019-2030 (US$ Million)
    Figure 13. Global Swedish Porphyria Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Swedish Porphyria Revenue Market Share by Region (2019-2030)
    Figure 15. Global Swedish Porphyria Sales 2019-2030 ((Units)
    Figure 16. Global Swedish Porphyria Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Swedish Porphyria Sales YoY (2019-2030) & (Units)
    Figure 18. US & Canada Swedish Porphyria Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Swedish Porphyria Sales YoY (2019-2030) & (Units)
    Figure 20. Europe Swedish Porphyria Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Swedish Porphyria Sales YoY (2019-2030) & (Units)
    Figure 22. China Swedish Porphyria Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Swedish Porphyria Sales YoY (2019-2030) & (Units)
    Figure 24. Asia (excluding China) Swedish Porphyria Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Swedish Porphyria Sales YoY (2019-2030) & (Units)
    Figure 26. Middle East, Africa and Latin America Swedish Porphyria Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Swedish Porphyria Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Swedish Porphyria in the World: Market Share by Swedish Porphyria Revenue in 2023
    Figure 29. Global Swedish Porphyria Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Swedish Porphyria Sales Market Share by Type (2019-2030)
    Figure 31. Global Swedish Porphyria Revenue Market Share by Type (2019-2030)
    Figure 32. Global Swedish Porphyria Sales Market Share by Application (2019-2030)
    Figure 33. Global Swedish Porphyria Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Swedish Porphyria Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Swedish Porphyria Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Swedish Porphyria Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Swedish Porphyria Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Swedish Porphyria Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Swedish Porphyria Sales Share by Country (2019-2030)
    Figure 40. U.S. Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Swedish Porphyria Sales Market Share by Type (2019-2030)
    Figure 43. Europe Swedish Porphyria Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Swedish Porphyria Sales Market Share by Application (2019-2030)
    Figure 45. Europe Swedish Porphyria Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Swedish Porphyria Revenue Share by Country (2019-2030)
    Figure 47. Europe Swedish Porphyria Sales Share by Country (2019-2030)
    Figure 48. Germany Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 49. France Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 50. UK Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 53. China Swedish Porphyria Sales Market Share by Type (2019-2030)
    Figure 54. China Swedish Porphyria Revenue Market Share by Type (2019-2030)
    Figure 55. China Swedish Porphyria Sales Market Share by Application (2019-2030)
    Figure 56. China Swedish Porphyria Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Swedish Porphyria Sales Market Share by Type (2019-2030)
    Figure 58. Asia Swedish Porphyria Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Swedish Porphyria Sales Market Share by Application (2019-2030)
    Figure 60. Asia Swedish Porphyria Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Swedish Porphyria Revenue Share by Region (2019-2030)
    Figure 62. Asia Swedish Porphyria Sales Share by Region (2019-2030)
    Figure 63. Japan Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 67. India Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Swedish Porphyria Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Swedish Porphyria Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Swedish Porphyria Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Swedish Porphyria Revenue Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Swedish Porphyria Revenue Share by Country (2019-2030)
    Figure 73. Middle East, Africa and Latin America Swedish Porphyria Sales Share by Country (2019-2030)
    Figure 74. Brazil Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 75. Mexico Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 76. Turkey Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 77. Israel Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 78. GCC Countries Swedish Porphyria Revenue (2019-2030) & (US$ Million)
    Figure 79. Swedish Porphyria Value Chain
    Figure 80. Swedish Porphyria Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)